Learning Hub

< BACK iPROLEPSIS Newsletter No. 10 Nov 6, 2025 Latest News from iPROLEPSIS Welcome to the tenth edition of the iPROLEPSIS newsletter, where we share the latest updates and progress from the project. iPROLEPSIS project newsletter Issue No. 10_Nov 2025 .pdf Download PDF • 9.31MB Newsletter 10 cover for article.png Newsletter 10 cover for article.png 1/1 PREVIOUS NEXT

< BACK Advancing Digital Health Solutions: Updates on User Research and Co-Creation Nov 20, 2023 Navigating the Development of PDPID-App, Insights from Co-Creation Sessions Updates on user research and co-creation The current status of user research and co-creation involves a dedicated focus on advancing the development of the PDPID-app , scheduled for delivery before January 2023. In early October 2023, Erasmus MC ( EMC) conducted a co-creation session with patient partners to assess the general looks and feel of the User Interface (UI) and identify points to improve the app's usability. In apps used for medical data collection, it is of utmost importance that users know what is expected of them. Furthermore, users should be engaged with the app to a level that minimises missing data. Following this, bi-weekly meetings with patient partners were established to maintain alignment with their ideas. Furthermore, project partner FACULDADE DE MOTRICIDADE HUMANA (FMH-ULISBOA) is developing storyboards for the personalised gaming suite . Three co-creation sessions have been executed: one with healthcare professionals and two with patient partners. Additionally, project partners The Centre for Research and Technology Hellas (CERTH) and FACULDADE DE MOTRICIDADE HUMANA (FMH-ULISBOA) have been working with the clinical partners to identify movements for the video analysis tasks that will be included in the iPROLEPSIS-PDPID study. Multiple hand gestures and full-body movements have been identified for further assessment. Key take-away messages The development of the Digital health tools is still at an early stage. However, several take-away messages from the discussions about the PDPID app are : The general looks and UI of the miPROLEPSIS app have been approved by the patient partners. Even though the PDPID-app is a data-collection app for research purposes, patients find it of utmost importance that they can review their own data entries. Participants indicated that the app needs to improve its’ visual cues of when they need to perform certain activities. Take-away messages from the discussions about personalised gaming suite development: Smart games meant for disease management should be highly tailored to the capabilities of the patients. Gaming is for patients a way of relaxation, any game designed should not incorporate any stressful factors. Patient partners expressed interest in the proposed gaming categories. Future steps Future steps involve initiating a round of user testing for the PDPID version of the miPROLEPSIS app to validate designs with patients not involved in the development process. Subsequently, attention will shift to developing recommendation systems for physical activity and diet, incorporating insights from experts in the field (occupational therapists, physical therapists & nutritionists) and patients themselves. For the personalised gaming suite, the completion of the storyboard is planned for the end of December 2023, when the development of the first prototypes will follow. mIPROLEPSIS app.png mIPROLEPSIS app.png 1/1 PREVIOUS NEXT

< BACK The miPROLEPSIS App Now Available for Android Devices on Google Play Store Sep 30, 2024 A data collection tool for the iPROLEPSIS-PDPID study now on Android As of 30 September 2024, the miPROLEPSIS app is available for Android devices on the Google Play Store. The miPROLEPSIS PDPID Study application functions as a data collection tool, utilized during the PDPID study, in order to produce datasets used for model generation and training. The app utilises both continuous and unobtrusive data collection (via bluetooth) from wearable devices, as well as user interactions (questionnaires, reporting etc). miPROLEPSIS - Apps on Google Play 1/1 PREVIOUS NEXT

< BACK Season's Greetings from iPROLEPSIS Dec 21, 2023 Merry Christmas and Happy New Year! No updates and announcements, simply warmth, joy, health and peace from the iPROLEPSIS consortium to all our community! Thank you for being a part of our journey. merry (1).png merry (1).png 1/1 PREVIOUS NEXT

< BACK ChatGPT in Nutrition: Trends, Challenges and Future Directions Jun 27, 2024 Exploring the Role of AI in Shaping the Future of Personalised Nutrition Introducing our latest iPROLEPSIS publication, "ChatGPT in Nutrition: Trends, Challenges, and Future Directions" , presented at PETRA 2024. This study explores the evolving role of AI in personalized nutrition. Abstract: A healthy and balanced diet is of paramount importance to the physical and psychological well-being of an individual, since unhealthy dietary choices have been linked with the occurrence of non-communicable diseases. Recent technological advances has led to the development of large language models, such as ChatGPT that has been widely adopted as a convenient tool for creating meal plans and obtaining nutritional information. This work aims to provide a thorough review of the scientific work performed so far regarding the use of ChatGPT in the field of nutrition. In this survey, the advantages and limitations of ChatGPT in different aspects of nutrition are pinpointed, while the challenges from the use of ChatGPT in nutrition are identified and discussed. Future research directions are also proposed to assist researchers towards the development of more effective nutrition recommendation systems. Read the full publication: https://zenodo.org/records/13142880 ChatGPT in Nutrition .pdf Download PDF • 620KB 1/1 PREVIOUS NEXT

< BACK The miPROLEPSIS Joint Landmarker App Now Available for Android Devices on Google Play Store Sep 25, 2024 A New Tool for Assessing Physical Function in Psoriatic Arthritis As of 25 September 2024, the miPROLEPSIS Joint Landmarker app is available for Android devices on the Google Play Store. This app is a research app that accompanies the miPROLEPSIS app and aims to assess the physical functioning of people with Psoriatic Arthritis. More specifically, a set of 6 hand and body exercises are given and the user is asked to perform them in front of the smartphone camera. The app uses the collected videos to extract skeletal data (coordinates of skeletal joints), which are then sent to a cloud for further processing. Through the skeletal data processing, the aim is to identify whether a patient with Psoriatic Arthritis have difficulties in performing certain hand and body actions. miPROLEPSIS Joint Landmarker - Apps on Google Play 1/1 PREVIOUS NEXT

< BACK Psoriatic Arthritis Awareness Day 2024 Sep 27, 2024 Advancing Psoriatic Arthritis Care with Technology and Research On 28 September, we celebrate Psoriatic Arthritis Awareness Day, a day dedicated to raising awareness about this condition and its impact on patients' lives. The iPROLEPSIS project is dedicated to improving our understanding and management of psoriatic arthritis. Did you know that psoriatic arthritis affects 112 out of 100,000 adults worldwide? This condition causes inflammation, pain, and fatigue, significantly affecting daily life. Therefore, finding better ways to monitor and manage it is important. PROLEPSIS-PDPID Study The iPROLEPSIS-PDPID study focuses on using smart devices and clinical data to develop new AI-driven models for personalised monitoring and flare prediction. This innovative approach seeks to empower patients by providing them with the tools they need to understand their condition better. miPROLEPSIS App A digital tool designed to help patients in tracking their condition. By collecting data from smartphones and smartwatches, the app offers insights into disease triggers and prognosis. This personalised information can help patients manage their symptoms more effectively, leading to improved health outcomes. Collaborative Efforts Conducted across four countries - the Netherlands, UK, Portugal, and Greece - the iPROLEPSIS project brings together experts and patients to transform the care of psoriatic arthritis. Through collaboration, the project aims to develop innovative solutions that cater to the needs of patients, enhancing their quality of life. Join Us in Raising Awareness As we celebrate Psoriatic Arthritis Awareness Day, we invite you to join us in promoting better management and understanding of psoriatic arthritis. Together we can make a difference in the lives of those living with this condition. 1/1 PREVIOUS NEXT

< BACK Developing Exergames for Psoriatic Arthritis using Agile Storyboarding and Game Design Processes Jun 27, 2024 Enhancing Mobility and Quality of Life through Agile Co-Designed Exergames for Psoriatic Arthritis We are pleased to announce our latest study, "Developing Exergames for Psoriatic Arthritis using Agile Storyboarding and Game Design Processes", presented at PETRA 2024. This research, a part of the Horizon Europe iPROLEPSIS project, focuses on creating Exergames to improve physical activity and well-being for individuals with Psoriatic Arthritis. Abstract Serious Games (SGs) offer significant potential in healthcare for disease assessment and intervention, enhancing patients’ quality of life. Exercise SGs, or Exergames, promote physical activity and mobility in a gamified environment, encouraging tailored exercises based on individual abilities and needs. Here, within the Horizon Europe iPROLEPSIS project that targets Psoriatic Arthritis (PsA), we describe the design process of Exergames to address PsA symptoms, including morning stiffness, impaired finger/hand and wrist functionality, and motor asymmetry. From a methodological point of view, the storyboarding technique was adopted to facilitate the visualization of the proposed Exergame scenarios, including the graphical user interface, interactive game elements, narratives, characters, and contexts related to the PsA condition. This approach has been implemented within an agile game development methodology, which includes gathering feedback early on to iteratively refine both the game ideas and prototype. Informed by the results of the game design via two agile sessions incorporating 25 participants (PsA patients, clinicians, technology developers, facilitators/observers), the current efforts are focused on developing the game prototypes and corresponding mock-ups, preparing them for upcoming clinical validation trials. The Exergames development lays the groundwork for an innovative framework to improve gross and fine motor symptoms in PsA patients. This framework could inform healthcare providers and policymakers about its potential inclusion in routine PsA management. Read more: https://dl.acm.org/doi/10.1145/3652037.3663939 Developing Exergames for Psoriatic Arthritis using Agile .pdf Download PDF • 1.70MB 1/1 PREVIOUS NEXT

< BACK DHU extends Call for Twinnings Deadline until October 13! Sep 20, 2023 DigitalHealthUptake (DHU) project has extended the submission deadline of the twinning applications In a move that promises to fuel innovation and support the acceleration of digital health initiatives, we are thrilled to announce that our synergy partner project, the DigitalHealthUptake (DHU) project, has extended the submission deadline of the twinning applications until October 13, 2023. Why apply for the DHU Call for Twinnings? Participating in the DHU Call for Twinnings offers a multitude of advantages: Knowledge Exchange: Engage in fruitful knowledge sharing with fellow innovators, gaining fresh insights and perspectives. Access to Innovative Solutions: Unlock the door to cutting-edge digital health solutions that can revolutionise healthcare in Europe. Networking Opportunities: Connect with a diverse and influential network of industry experts, thought leaders, and change-makers. Funding for Transformation: Access financial support to implement transformative digital applications, accelerating progress and impact in the health and care domain. What types of twinnings are being funded? Citizen/patient-focused twinning topics: Digital tools to support health education (health literacy), digital health literacy mHealth systems, wearable devices for monitoring and prevention, alerts, reminders Digital tools to support patient feedback and reporting of outcomes and experiences Digital tools to support proactive prevention, self-management, homecare, telemonitoring Tele-mentoring/coaching, virtual consultations, virtual coach, personal assistant ICT supporting adherence to medication and care plans Robotics (e.g., companion robots) Use of digital therapeutics Tools and services supporting independent living, ambient assisted living technologies, telecare Care practitioner-focused twinning topics: Advanced digital tools to support Integrated Care, including integration of health and social care services Interoperable digital solutions to support person-centred and integrated care Regional and national Electronic Health Record (EHR) systems and ePrescription solutions enabling person-centred care Regional, national and local Electronic Integrated Care Record (EICR) systems, integration of EHR and social care records Digital shared care plans (e.g., support to multi-disciplinary team(s)) Decision support for multi-morbidity and polypharmacy management ICT support for management of frailty ICT support for falls prevention eLearning to support workforce development for person-centred integrated care Important links Ready to take the next step? Here are some crucial links you'll need: How to apply: Access the application form here . Q&A document: Got questions? Check our Q&A document for answers. Webinar recording: Missed our informative webinar on the call? No problem! You can watch the recording here. Don't miss out on this opportunity to accelerate digital health solutions in Europe. Apply now! News & Events iPROLEPSIS - events.png News & Events iPROLEPSIS - events.png 1/1 PREVIOUS NEXT

< BACK Fostering Synergy: iPROLEPSIS and DHU Partnership Aug 31, 2023 Exploring Collaboration and Synergies with Digital Health Uptake Project This week, we had a fantastic opportunity to connect with Anett Ruszanov, the representative of empirica, the coordinating organisation of the Digital Health Uptake (DHU) project. Our discussion focused on exploring collaboration and networking opportunities between iPROLEPSIS and DHU. The Digital Health Uptake (DHU) project, funded through the Digital Europe Programme, is dedicated to aligning policies, strategies, instruments, and activities to promote the adoption of digital health solutions and services across Europe. DHU's efforts are categorized into three key aspects: RADAR, KNOWLEDGE COMMUNITY, and ACCELERATOR. During the conversation, Prof. Leontios Hadjileontiadis, iPROLEPSIS project coordinator, and Anett Ruszanov discussed possibilities for collaboration and synergies, such as mutual promotion of relevant news and events through websites, newsletters, and social media, as well as potential co-organisation of events. This dynamic conversation paved the way for the next steps in our partnership. We greatly appreciate this initiative and eagerly anticipate the next steps in our partnership! News & Events iPROLEPSIS - news.png News & Events iPROLEPSIS - news.png 1/1 PREVIOUS NEXT

< BACK Hot topic debate: preventing psoriatic arthritis in patients with psoriasis Nov 13, 2024 Preventing PsA: Insights from the IFPA-WPPA 2024 Conference Conference IFPA-WPPA 2024 Conference At the 7th World Psoriasis & Psoriatic Arthritis (IFPA-WPPA) Conference , experts discussed whether effective treatment for psoriasis (PsO) could help prevent the onset of psoriatic arthritis (PsA). In this session, Prof. Laura Coates highlighted early intervention as a key strategy for PsA prevention. Supporting these efforts, the iPROLEPSIS consortium, active across Europe, is exploring digital, non-pharmacological tools aimed at improving patient outcomes. These include stress management games designed to offer additional support for people with PsO, focusing on prevention beyond medications alone. Alongside iPROLEPSIS, other studies, including the PAMPA study and HIPPOCRATES Prospective Observational Study (HPOS), are investigating early detection and intervention strategies. Digital tools such as the Psorcast app, along with new apps from iPROLEPSIS, are being developed to monitor psoriasis patients for early signs of PsA. These efforts aim to pave the way for more personalised and preventive care approaches. Abstract Can effective treatment of psoriasis (PsO) prevent the development of psoriatic arthritis (PsA)? In a Hot Topic Debate at the 7th World Psoriasis & Psoriatic Arthritis Conference, Dr. Soriano and Dr. Ogdie, both experts in the field, presented contrasting views based on existing research and clinical studies.1 Dr. Soriano argued that biologic treatments for PsO may reduce PsA risk, citing several retrospective studies. On the other hand, Dr. Ogdie argued that current observational data are plagued by biases, making it difficult to conclude whether biologics play a protective role. The session outlined the complexity of this issue, with both speakers agreeing on the need for prospective randomised controlled trials, such as the ongoing PAMPA study, to provide definitive answers. Prof. Laura Coates added that identifying at-risk patients and intervening early to potentially prevent PsA may point to a strategic research approach to address these unanswered questions. Read the full article: https://conferences.medicom-publishers.com/proceedings/proceedings-in-dermatology/7th-ifpa-wppa-conference/preventing-psoriatic-arthritis-in-patients-with-psoriasis/ 1/1 PREVIOUS NEXT

< BACK iPROLEPSIS patient survey Jun 26, 2023 iPROLEPSIS patient survey launched Have you been diagnosed with Psoriatic Arthritis ? Then we would love to get your opinion! 👉 The upcoming 4 years our European Research Team will dedicate itself to the iPROLEPSIS project. Within this project we will develop Digital Health Tools that can help you monitor your condition and can aid in the management of your Psoriatic Arthritis by providing personalised recommendations 🚀 This research was initiated by many conversations with people with Psoriatic Arthritis , who stated that the process of Trial and Error with regard to finding balance in life and gaining control over this condition is very long and complicated. We kindly ask you to complete our survey about the Digital Health Tools to be developed. This way we can design them as is important for you! 👉 The survey is available in 4 different languages available through the following links: 🔗 English: https://lnkd.in/eMhFEHMX 🔗 Greek: https://lnkd.in/en3cs-bV 🔗 Portuguese: https://lnkd.in/dy76S8Rg 🔗 Dutch: https://lnkd.in/ecTgfJh9 Your participation and feedback are valuable to us 👋 Together, we can shape the future of Psoriatic Arthritis management! For further information or if you have any questions, please visit: 🌐 Website: www.iprolepsis.eu 👍 LinkedIn: https://lnkd.in/dnrTP8rC 🐦 Twitter: https://twitter.com/iprolepsis Thank you in advance for contributing your opinion. Your voice matters! News & Events iPROLEPSIS - events.png News & Events iPROLEPSIS - events.png 1/1 PREVIOUS NEXT